We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/2/2018 16:05 | Amazed to see a few take profits at 30p. This could be £3.30 and still be undervalued. Most have no vision at all. | hughwilson | |
12/2/2018 15:30 | Can't keep a good share down lol | ch1rp | |
12/2/2018 14:55 | Yes, all going well, we could get an update on the viagra soon, and oddly some additional patents | urigem | |
12/2/2018 14:47 | Strong buying today. People are doing the research and likin* what they see.Viagra, for example specifically reformulated for the Erectile Dysfunctional Market:https://www.s | ch1rp | |
12/2/2018 12:51 | falia, i think everyone here has something to contribute. You should contribute silence. | jimbobaroony | |
12/2/2018 12:34 | and it seems unlike IMM, which is a 50/50 chance of success -------------------- you need to get a new calculator | herschel k | |
12/2/2018 12:33 | and it seems unlike IMM, which is a 50/50 chance of success , N4p , reformulates existing drugs, which have already been provan, the company just makes the drugs better and have patents. | happyman7 | |
12/2/2018 12:23 | With Japan next week and AZ's collaboration with nuvec this will rerate to 37p on this news alone. However, news flow/ impending deals do look more advanced that the timescale N4P have set out:https://www.n4ph | ch1rp | |
12/2/2018 12:15 | indeed, the informed and knowledgeable posters on here believe this share has a long way to go, obviously traders come and go, with the m/c £26M and lots of big deals in the pipeline, this looks a better opportunity than the like of VRS and IMM, with their inflated m/caps, after their good runs. | happyman7 | |
12/2/2018 12:10 | This share doesn't need ramping. At 30p the mc is just under £26 million. | parob | |
12/2/2018 12:07 | Threw a bit more money at this on Friday and delighted with the rise today. Its a nice little earner. | top tips | |
12/2/2018 12:06 | i think falia is the only dipstick here, he pops up all over the place | happyman7 | |
12/2/2018 12:04 | Thanks rampers. Managed to sell at a slight profit after being at a loss last week. :). Will buy back once you have moved on to the next share.... | babbler | |
12/2/2018 12:03 | would you care to give some analaysis falia, like some other very good posters have done? | happyman7 | |
12/2/2018 12:00 | looks like we are about to go past 30p very soon | falia | |
12/2/2018 12:00 | its gonna be a fun week guys, all sells should be snapped up very easily | falia | |
12/2/2018 11:57 | Every little dip being bought into. | parob | |
12/2/2018 11:40 | we have all week to go yet , gonna be huge | falia | |
12/2/2018 11:40 | Getting well and truly squeezed. Looks like we will be kissing goodbye to 30p once and for all in the next few minutes ... | jakleeds | |
12/2/2018 11:36 | Rampers! ?iPhone will not let me type that | urigem | |
12/2/2018 11:35 | Falia - no we won't - So the tampers are here now then? | urigem | |
12/2/2018 11:33 | if everything goes according to plan this year,we will be trading £5 upwards the minimum | falia | |
12/2/2018 11:31 | Hopefully that’s the 28p resistance level gone for good ... | jakleeds |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions